Screening and surveillance of hereditary upper GI cancers
Best Practice & Research Clinical Gastroenterology · 2025-03 · 75 · 102018
DOI: 10.1016/j.bpg.2025.102018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Best Practice & Research Clinical Gastroenterology, 2025-03. Verfasst von Lianlian Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Early Cancer Institute, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK; Renmin Hospital of Wuhan University, Wuhan University, W…. Hauptthemen laut MEDLINE: Early Detection of Cancer, Stomach Neoplasms, Neoplastic Syndromes, Hereditary, Esophageal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: China Scholarship Council, Cancer Research UK, Medical Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Early Cancer Institute, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK; Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.
- Early Cancer Institute, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. Electronic address: md460@cam.ac.uk.
Förderung
- China Scholarship Council
- Cancer Research UK
- Medical Research Council
- Cancer Research UK Cambridge Institute, University of Cambridge
Zitieren
APA
Wu, L., & di Pietro, M. (2025). Screening and surveillance of hereditary upper GI cancers. Best Practice & Research Clinical Gastroenterology, 75, 102018. https://doi.org/10.1016/j.bpg.2025.102018
Vancouver
Wu L, di Pietro M. Screening and surveillance of hereditary upper GI cancers. Best Practice & Research Clinical Gastroenterology. 2025;75:102018. doi:10.1016/j.bpg.2025.102018
BibTeX
@article{Wu2025,
author = {Wu, Lianlian and di Pietro, Massimiliano},
title = {Screening and surveillance of hereditary upper GI cancers},
journal = {Best Practice & Research Clinical Gastroenterology},
year = {2025},
volume = {75},
pages = {102018},
doi = {10.1016/j.bpg.2025.102018}
}
EUVIMED